Editorials
Non-commercial Drugs Any discussion of the research policy of the pharmaceutical industry must take account of two factors that have dominated the last decade: consumerism and inflation. The thalidomide disaster led to a wave of public disenchantment in which pharmaceutical firms were pilloried as indifferent to the safety of their drugs, and in consequence governments throughout the world introduced drug-regulatory agencies. Detailed and prolonged tests were required by the agencies, but in addition the major manufacturers themselves adopted a defensive approach to the development of drugs, for at all costs they wished to avoid the adverse publicity that would result from any suspicion of inadequate safety testing. If anything, testing has become more and more stringent so that nowadays any new drug has to go through several years of animal toxicity studies before equally extensive clinical trials can be started. At the same time inflation has not spared the pharmaceutical industry: in common with other manufacturers, drug firms have found their costs rising rapidly. The result of these two trends has been that the minimum cost of developing and testing a drug is now of the order of £1 million, and it often amounts to much more.
With development costs of this order, it is inevitable that research programmes have become concentrated on drugs for which there is likely to be a large marketand in practice (as became clear at the Medico-Pharmaceutical Forum meeting reported in December, p 885) this means that there is little prospect of research by the pharmaceutical industry into diseases limited to developing countries or into rare diseases. Peptic ulcer, arthritis, and hypertension attract research interest; porphyria does not.
Recently there has been a further reason for disquiet about the problem of providing drugs for patients with rare diseaseshighlighted by Dr John Walshe's difficulties with his patients with the disorder of copper metabolism, Wilson's disease (Walshe 1975) . Twenty years ago, when Walshe first postulated that the chelating agent penicillamine might be an effective treatment for Wilson's disease, he did some simple toxicity tests on rats in his own laboratory, took a test dose himself, and then found little difficulty in persuading the firm of Merck, Sharp & Dohme to provide him with supplies. That was all before the new, cautious attitudes provoked by thalidomide. Unfortunately some of his patients have become intolerant of penicillamine (which, by chance, has become a commercial success from its use in rheumatoid arthritis) and he has had to find an alternative, triethylene tetramine dichloride or trien. This time, however, he has been unable to find any pharmaceutical firm willing to supply him with the drug. It is not difficult to make, nor is it expensive; but quite simply no firm has been willing to accept the risk to its reputation of supplying a drug that has not gone through the full range of conventional toxicity tests and clinical trials.
It would be unfair to blame the Medicines Act for these difficulties, though its provisions do complicate the issue. An individual physician can apply for an exemption from the licensing authority and there are other alternatives, but all leave the doctor concerned carrying the risk of any civil liability for damage caused by the drug. The most satisfactory solutionas became apparent at an informal meeting in Cambridge (Lancet 1976) arranged recently by Dr Walshewould be for the supplies division of the DHSS to hold the licence in such cases, cooperating with the Government chemist for checks on quality control, and supplying the drug through one or more identified hospital pharmacists. A compromise along these lines seems likely in the case of trien; whether a precedent will be established remains to be seen. The Cat as an Experimental Animal'
Since the turn of the century, in Britain the cat has been the preeminent species for acute experiments. These classical investigations were of great importance in elucidating the mode of action and regulation of the cells and organs of the cardiovascular, respiratory, central and peripheral nervous systems, and more recently of neuroendocrine interrelationships. Information and theoretical considerations arising from these investigations have been very successfully applied to the understanding of function in man, particularly to the central and peripheral actions of drugs.
In the 1940s, in spite of a long history of domestication, cats were a neglected species as far as behavioural studies, nutrition, pathology and general care were concerned. There was no consolidated account of the problems, parasites and diseases likely to be encountered among the miscellaneous cats sold to laboratories by dealers at that period. Grumbles of colleagues in physiology and pharmacology suggested that these cats were unsuitable even for acute experiments, often dying during the initial anaesthetization before any experimental objectives could be attained, due to the use of unsuitable anaesthetic agents and to respiratory infection. At that time many veterinarians regarded sick cats as incurable; indeed the Feline Advisory Bureau was founded in 1958 to help owners and breeders by a member of the public, Mrs Joan Judd; the FAB has gone from strength to strength supporting research financially and providing a forum for discussions between breeders, veterinarians and biological scientists.
We set out to improve the standard of health of the cats, first, by improving the environment of the animal house and reducing bacterial contamination by improving ventilation, lighting, heating, cleaning and feeding; secondly, by designing cages adapted to the particular needs of the cat as well as the convenience of the technician or breeder: collapsible holding cages (Scott 1952) which would fit into an autoclave, cages for metabolic studies (Humphreys & Scott 1962 ) and for breeding (Jackson & Scott 1970) were designed and built with the help of grants from the University of London and the Medical Research Council; thirdly, the introduction of commercial vaccines enabled us to control the devastating enteric virus (FEV, panleukopenia) which afflicted laboratory and zoo cats alike. Within a comparatively short time losses among adult cats in the animal house and under experiment were negligible. But losses among groups of kittens were still severe, due to horizontally transmittted rhinotracheitis and oncogenic viruses. These affect appetite and therefore growth, so that it was difficult to interpret the results of nutritional investigations. A recent study showed that while a group of 20 kittens vaccinated for FEV from 8 litters gained at a mean rate of 75 g a week on a particular food, 9 siblings from the same litters fed on the same food but distributed singly to households without cats gained 125 g a week. But a group of 8 kittens derived from 3 pathogen-free mothers on a similar diet gained at the same rate as the isolated kittens. The depressed growth of the first group was therefore due to subclinical infection rather than to defects in the diet. Thus control of disease by constant vigilance, and monitoring, are needed to obtain valid results from experiments using cats. The work of the MRC Laboratory Animals Centre in evolving methods for producing and maintaining specified pathogen free cats has been of the greatest importancewhile the investigations of Povey at Bristol and Jarrett in Glasgow have increased our knowledge of the nature and behaviour of the viruses concerned, as well as directly benefiting domestic, pedigree and laboratory cats.
Observations on the normal physiology of reproduction in the cat have provided basic information for experimental studies in the fields of hormonal control and nutritional requirements, supported by grants from the petfood industry. The better understanding of the reproductive process has led to greatly improved standards of care and feeding in domestic cats. Geneticists such as Searle (1968) and Robinson (1971) have been interested in the colour and coat mutants popular with the breeders of pedigree cats, and pharmacologists in the variation in individual responses to drugs in relation to the heredity of defects in specific cell systems, while studies of mutant genes in urban cat populations have contributed to population genetics, and demonstrated the operation of two selective pressures, natural selection and human preference for certain phenotypes. -Part of our interest in cats has been for their own sake as true carnivores, showing highly distinctive behavioural, physiological and biochemical adaptations. Protein of animal origin must form at least 25 % of the calories in the diet and in view of world shortages and high cost of animal protein attempts are constantly being made to produce forms of vegetable protein suitable for the cat; unfortunately acceptability tends to be poor for these manufactured products.
This high protein diet coupled with low water intake produces problems in getting rid of excess nitrogen, sulphur and phosphorus, with the result that the struvite crystals which form in the very concentrated urine may obstruct the distal part of the urinary tract in the tom cat. The remainder of the calories are provided in nature mainly by saturated fats, although in domestication a high proportion of this fat has been replaced by cheaper cooked starches. There is evidence that many cats are intolerant of lactose and high levels of sucrose. The cat has a requirement for unsaturated fat, but is unable to desaturate polyunsaturated fats such as marine fish oils in large amounts (Rivers et al. 1976) . Gershoff (1962) showed that feeding tuna fish produced steatitis (yellow fat disease), preventable to some extent by increasing the level of tocopherol in the diet.
Formerly, cats both in homes and in zoos tended to be fed on muscle meats and offals exclusively. This calcium deficient diet produced osteoporosis, followed by fractures of vertebrae and limb bones in growing kittens and young zoo felids. Calcium deficiency also occurred in lactating queens and their young litters as a result of this type of feeding. Modern diets with added calcium, based on our investigations, have eliminated this problem (Scott 1968) . However, some cats have become addicted to liver, resulting in an excessive intake of retinol (vitamin A). Severe bony changes occurred with the formation of exostoses around joints, the cat became rigid, particularly in the forelimbs and neck. The condition improved when the excess vitamin was removed from the diet (Clark 1970) .
In studying protein requirements in the cat it was found that many cats showed loss of light reflexes due to degeneration of the retina. Although this condition was most severe when associated with a low retinol intake, it also occurred on high level intakes (Scott et al. 1964) . Recently this deficiency has been shown to be due to deficiency in plasma retinol binding protein produced by the liver (Glover 1974) on low protein or amino-acid imbalanced diets. The cat is the only animal at present known which is unable to convert ,B-carotene into retinol. It is a matter of speculation whether the cat became a carnivore because it was unable to convert carotene, or whether it lost the ability because it obtained more than adequate amounts of retinol through the livers of its prey.
Cats are useful models and relate well to human beings in studying the transmission of vitamins and minerals to the fetus and newborn, since the collection of blood samples is relatively easy, and it is even possible to extend observations by removing kittens sequentially during the last part of pregnancy. However, only by experiments is it possible to determine whether any particular function in the cat represents a biological generalization applicable to other species, or whether that function is modified and specialized only for the survival of cats.
Whatever the outcome of investigations using cats in terms of the original objectives, it is plain that active research has resulted in improvements in the health and the standard of care of pet domestic cats. 
